Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by Bigchunguson Jun 10, 2019 10:03pm
70 Views
Post# 29813876

DionyMed Brands Inc. Announces First Quarter 2019 n Kills It

DionyMed Brands Inc. Announces First Quarter 2019 n Kills It14.2mm USD or 19mm CAD Q1 revenue. Approaching an annual run rate of 80mm CAD and and a mere 100mm cap. This e-commerce platform distributes to over 900 retailers and makes thousands of direct to consumer deliveries daily and is expanding rapidly. This puts DYME in approx 13th on the U.S. overall cannabis revenue generator and exceeds many established Canadian producers sales, including Aphria and other noteworthy LPs. Who wouldn’t want cannabis delivered straight to your door? This company is largely under the radar and worth noting, a near 52w low. Super low float, so this could easily hit the analysts target of $6.00 from its current $2.08 in short order. Anticipated 2019 revenue of 162 million CAD

Order here:  https://www.orderchill.com/

https://www.newcannabisventures.com/cannabis-company-revenue-ranking/
Bullboard Posts